185 related articles for article (PubMed ID: 25080433)
1. Altered endosome biogenesis in prostate cancer has biomarker potential.
Johnson IR; Parkinson-Lawrence EJ; Shandala T; Weigert R; Butler LM; Brooks DA
Mol Cancer Res; 2014 Dec; 12(12):1851-62. PubMed ID: 25080433
[TBL] [Abstract][Full Text] [Related]
2. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
Johnson IR; Parkinson-Lawrence EJ; Keegan H; Spillane CD; Barry-O'Crowley J; Watson WR; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
Oncotarget; 2015 Nov; 6(35):37919-29. PubMed ID: 26473288
[TBL] [Abstract][Full Text] [Related]
3. Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.
Johnson IR; Parkinson-Lawrence EJ; Butler LM; Brooks DA
Prostate; 2014 May; 74(5):547-60. PubMed ID: 24435746
[TBL] [Abstract][Full Text] [Related]
4. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology.
Kuronita T; Eskelinen EL; Fujita H; Saftig P; Himeno M; Tanaka Y
J Cell Sci; 2002 Nov; 115(Pt 21):4117-31. PubMed ID: 12356916
[TBL] [Abstract][Full Text] [Related]
5. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
Martini C; Logan JM; Sorvina A; Gordon C; Beck AR; S-Y Ung B; Caruso MC; Moore C; Hocking A; Johnson IRD; Li KL; Karageorgos L; Hopkins AM; Esterman AJ; Huzzell C; Brooks RD; Lazniewska J; Hickey SM; Bader C; Parkinson-Lawrence E; Weigert R; Sorich MJ; Tewari P; Martin C; O'Toole S; Bates M; Ward M; Mohammed B; Keegan H; Watson W; Prendergast S; Heffernan S; NiMhaolcatha S; O'Connor R; Malone V; Carter M; Ryan K; Brady N; Clarke A; Sokol F; Prabhakaran S; Stahl J; Klebe S; Samaratunga H; Delahunt B; Selemidis S; Moretti KL; Butler LM; O'Leary JJ; Brooks DA
Pathology; 2023 Feb; 55(1):40-51. PubMed ID: 36089417
[TBL] [Abstract][Full Text] [Related]
6. BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells.
Harris JL; Richards RS; Chow CW; Lee S; Kim M; Buck M; Teng L; Clarke R; Gardiner RA; Lavin MF
PLoS One; 2013; 8(9):e73880. PubMed ID: 24040105
[TBL] [Abstract][Full Text] [Related]
7. RILP is required for the proper morphology and function of late endosomes.
Progida C; Malerød L; Stuffers S; Brech A; Bucci C; Stenmark H
J Cell Sci; 2007 Nov; 120(Pt 21):3729-37. PubMed ID: 17959629
[TBL] [Abstract][Full Text] [Related]
8. Integration of GPCR Signaling and Sorting from Very Early Endosomes via Opposing APPL1 Mechanisms.
Sposini S; Jean-Alphonse FG; Ayoub MA; Oqua A; West C; Lavery S; Brosens JJ; Reiter E; Hanyaloglu AC
Cell Rep; 2017 Dec; 21(10):2855-2867. PubMed ID: 29212031
[TBL] [Abstract][Full Text] [Related]
9. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
Liu T; Mendes DE; Berkman CE
Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
[TBL] [Abstract][Full Text] [Related]
10. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.
Hansen AG; Arnold SA; Jiang M; Palmer TD; Ketova T; Merkel A; Pickup M; Samaras S; Shyr Y; Moses HL; Hayward SW; Sterling JA; Zijlstra A
Cancer Res; 2014 Mar; 74(5):1404-15. PubMed ID: 24385212
[TBL] [Abstract][Full Text] [Related]
11. γ2-Adaptin is functioning in the late endosomal sorting pathway and interacts with ESCRT-I and -III subunits.
Döring T; Gotthardt K; Stieler J; Prange R
Biochim Biophys Acta; 2010 Nov; 1803(11):1252-64. PubMed ID: 20708039
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
13. UIM domain-dependent recruitment of the endocytic adaptor protein Eps15 to ubiquitin-enriched endosomes.
Gucwa AL; Brown DA
BMC Cell Biol; 2014 Sep; 15():34. PubMed ID: 25260758
[TBL] [Abstract][Full Text] [Related]
14. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Nagai K; Nakahata S; Shimosaki S; Tamura T; Kondo Y; Baba T; Taki T; Taniwaki M; Kurosawa G; Sudo Y; Okada S; Sakoda S; Morishita K
Cancer Med; 2014 Aug; 3(4):1085-99. PubMed ID: 24890018
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Hahm ER; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
[TBL] [Abstract][Full Text] [Related]
16. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
Windus LC; Glover TT; Avery VM
Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
[TBL] [Abstract][Full Text] [Related]
17. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
18. TSG101 interacts with the androgen receptor and attenuates its expression through the endosome/lysosome pathway.
Lin YM; Chu PH; Ouyang P
Biochem Biophys Res Commun; 2018 Sep; 503(1):157-164. PubMed ID: 29859188
[TBL] [Abstract][Full Text] [Related]
19. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes.
Nada S; Hondo A; Kasai A; Koike M; Saito K; Uchiyama Y; Okada M
EMBO J; 2009 Mar; 28(5):477-89. PubMed ID: 19177150
[TBL] [Abstract][Full Text] [Related]
20. ESCRT-0 protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is targeted to endosomes independently of signal-transducing adaptor molecule (STAM) and the complex formation with STAM promotes its endosomal dissociation.
Kojima K; Amano Y; Yoshino K; Tanaka N; Sugamura K; Takeshita T
J Biol Chem; 2014 Nov; 289(48):33296-310. PubMed ID: 25296754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
